$TIRX
Tian Ruixiang Holdings Ltd

2023 Q4 Form 20-F Financial Statement

#000141057824001091 Filed on July 17, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023
Revenue $519.4K $1.244M
YoY Change 27.85% -7.96%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.608M $4.261M
YoY Change 9.29% -32.05%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $610.00 $1.631K
YoY Change -93.9% -92.86%
% of Gross Profit
Operating Expenses $1.608M $4.261M
YoY Change 9.29% -33.64%
Operating Profit -$3.016M
YoY Change -40.49%
Interest Expense $263.8K $732.0K
YoY Change -26.55% 70.22%
% of Operating Profit
Other Income/Expense, Net -$1.810K $723.7K
YoY Change -99.48% 77.22%
Pretax Income -$826.4K -$2.293M
YoY Change -29.86% -50.81%
Income Tax $141.3K $161.3K
% Of Pretax Income
Net Earnings -$967.7K -$2.454M
YoY Change -18.02% -47.61%
Net Earnings / Revenue -186.32% -197.23%
Basic Earnings Per Share -$3.87
Diluted Earnings Per Share -$1.44 -$3.87
COMMON SHARES
Basic Shares Outstanding 633.3K
Diluted Shares Outstanding 633.3K

Balance Sheet

Concept 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $26.80M $26.80M
YoY Change 2.37% 2.37%
Cash & Equivalents $2.383K
Short-Term Investments $26.80M $26.80M
Other Short-Term Assets $107.5K $761.6K
YoY Change -36.37% -11.45%
Inventory
Prepaid Expenses
Receivables $18.96K $18.96K
Other Receivables $0.00 $38.64K
Total Short-Term Assets $27.62M $27.62M
YoY Change -20.77% -20.77%
LONG-TERM ASSETS
Property, Plant & Equipment $6.280K $61.15K
YoY Change -27.72% -59.23%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Assets $7.861M $7.861M
YoY Change 4465.02% 4524.21%
TOTAL ASSETS
Total Short-Term Assets $27.62M $27.62M
Total Long-Term Assets $7.861M $7.861M
Total Assets $35.48M $35.48M
YoY Change 1.28% 1.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $1.149M $1.149M
YoY Change 27.62% 38.38%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.063M $3.063M
YoY Change 105.0% 105.56%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Liabilities $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.063M $3.063M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $3.063M $3.063M
YoY Change 97.76% 97.63%
SHAREHOLDERS EQUITY
Retained Earnings -$8.304M
YoY Change 43.15%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $32.42M $32.42M
YoY Change
Total Liabilities & Shareholders Equity $35.48M $35.48M
YoY Change 1.28% 1.28%

Cashflow Statement

Concept 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$967.7K -$2.454M
YoY Change -18.02% -47.61%
Depreciation, Depletion And Amortization $610.00 $1.631K
YoY Change -93.9% -92.86%
Cash From Operating Activities $232.7K $994.3K
YoY Change -293.93% -600.25%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities -$36.11M -$992.7K
YoY Change 24.94% -96.56%
Cash From Investing Activities -$36.11M -$992.7K
YoY Change 24.94% -96.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -280.0 -283.0
YoY Change
NET CHANGE
Cash From Operating Activities 232.7K 994.3K
Cash From Investing Activities -36.11M -992.7K
Cash From Financing Activities -280.0 -283.0
Net Change In Cash -35.88M -167.0
YoY Change 23.62% -100.0%
FREE CASH FLOW
Cash From Operating Activities $232.7K $994.3K
Capital Expenditures $0.00 $0.00
Free Cash Flow $232.7K $994.3K
YoY Change -293.93% -594.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q4 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001782941
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022Q4 us-gaap Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023 dei Document Type
DocumentType
20-F
CY2023 dei Document Registration Statement
DocumentRegistrationStatement
false
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-10-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--10-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Document Shell Company Report
DocumentShellCompanyReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-39925
CY2023 dei Entity Registrant Name
EntityRegistrantName
TIAN RUIXIANG Holdings Ltd
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
Room 1001
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
10 / F, No. 25, North East Third Ring Road
CY2023 dei Entity Address Address Line3
EntityAddressAddressLine3
Chaoyang District
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Beijing
CY2023 dei Entity Address Country
EntityAddressCountry
CN
CY2023 dei Security12b Title
Security12bTitle
Class A Ordinary Shares
CY2023 dei Trading Symbol
TradingSymbol
TIRX
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Document Accounting Standard
DocumentAccountingStandard
U.S. GAAP
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023 dei Auditor Firm
AuditorFirmId
587
CY2023 dei Auditor Name
AuditorName
RBSM LLP
CY2023 dei Auditor Location
AuditorLocation
New York
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2383
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2508
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
692692
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
692734
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
26797081
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
26179662
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
18960
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
51202
CY2023Q4 tirx Notes Receivable Current
NotesReceivableCurrent
0
CY2022Q4 tirx Notes Receivable Current
NotesReceivableCurrent
7500000
CY2023Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
0
CY2022Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
262192
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
0
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1369
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
107508
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
168957
CY2023Q4 us-gaap Assets Current
AssetsCurrent
27618624
CY2022Q4 us-gaap Assets Current
AssetsCurrent
34858624
CY2023Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
7800000
CY2022Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
0
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6280
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8688
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
54870
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
143438
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
0
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
20078
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
7861150
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
172204
CY2023Q4 us-gaap Assets
Assets
35479774
CY2022Q4 us-gaap Assets
Assets
35030828
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
623825
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
466878
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
726330
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
424987
CY2023Q4 tirx Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
481801
CY2022Q4 tirx Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
384893
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1173510
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
126530
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
57402
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
90800
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3062868
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1494088
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
54718
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
0
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
54718
CY2023Q4 us-gaap Liabilities
Liabilities
3062868
CY2022Q4 us-gaap Liabilities
Liabilities
1548806
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.025
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.025
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
44108774
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
42663012
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
0
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2000
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
0
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
0
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8303691
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5800817
CY2023Q4 tirx Statutory Reserve
StatutoryReserve
275150
CY2022Q4 tirx Statutory Reserve
StatutoryReserve
226253
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-3681845
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-3620712
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
32416512
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
33481622
CY2023Q4 us-gaap Minority Interest
MinorityInterest
394
CY2022Q4 us-gaap Minority Interest
MinorityInterest
400
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
32416906
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
33482022
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
35479774
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
35030828
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1244247
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1351909
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2790617
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2438248
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1764909
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2517497
CY2023 tirx Professional Fees Under General And Administrative Expenses
ProfessionalFeesUnderGeneralAndAdministrativeExpenses
1220367
CY2022 tirx Professional Fees Under General And Administrative Expenses
ProfessionalFeesUnderGeneralAndAdministrativeExpenses
1185930
CY2021 tirx Professional Fees Under General And Administrative Expenses
ProfessionalFeesUnderGeneralAndAdministrativeExpenses
1011053
CY2023 tirx Compensation And Related Benefits Under General And Administrative Expenses
CompensationAndRelatedBenefitsUnderGeneralAndAdministrativeExpenses
460791
CY2022 tirx Compensation And Related Benefits Under General And Administrative Expenses
CompensationAndRelatedBenefitsUnderGeneralAndAdministrativeExpenses
2691751
CY2021 tirx Compensation And Related Benefits Under General And Administrative Expenses
CompensationAndRelatedBenefitsUnderGeneralAndAdministrativeExpenses
948900
CY2023 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
141167
CY2022 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
654587
CY2021 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
566971
CY2022 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
123646
CY2023 us-gaap Operating Expenses
OperatingExpenses
4260573
CY2022 us-gaap Operating Expenses
OperatingExpenses
6420823
CY2021 us-gaap Operating Expenses
OperatingExpenses
5044421
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-3016326
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-5068914
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-2253804
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
731961
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
434406
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
315070
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8278
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-26042
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
18686
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
723683
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
408364
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
333756
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2292643
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4660550
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1920048
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
161339
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23639
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24529
CY2023 us-gaap Profit Loss
ProfitLoss
-2453982
CY2022 us-gaap Profit Loss
ProfitLoss
-4684189
CY2021 us-gaap Profit Loss
ProfitLoss
-1944577
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-5
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-32
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-28
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-2453977
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-4684157
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1944549
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.87
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.87
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-9.03
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-9.03
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.65
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.65
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
633336
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
633336
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
518655
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
518655
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
344425
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
344425
CY2023 us-gaap Profit Loss
ProfitLoss
-2453982
CY2022 us-gaap Profit Loss
ProfitLoss
-4684189
CY2021 us-gaap Profit Loss
ProfitLoss
-1944577
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-61134
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3717478
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
214123
CY2023 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-2515116
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-8401667
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1730454
CY2023 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-6
CY2022 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-89
CY2021 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-6
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2515110
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8401578
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1730448
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8638713
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
9886299
CY2021 tirx Stock Issued During Period Value Securities New Issues
StockIssuedDuringPeriodValueSecuritiesNewIssues
-22200344
CY2021 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1944577
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
214123
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
38994902
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
2888787
CY2022 tirx Appropriation To Statutory Reserve
AppropriationToStatutoryReserve
0
CY2022 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-4684189
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3717478
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
33482022
CY2023 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1450000
CY2023 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-2453982
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-61134
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
32416906
CY2023 us-gaap Profit Loss
ProfitLoss
-2453982
CY2022 us-gaap Profit Loss
ProfitLoss
-4684189
CY2021 us-gaap Profit Loss
ProfitLoss
-1944577
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1631
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
22853
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
27447
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
78126
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
185421
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
227661
CY2023 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
0
CY2022 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
123646
CY2021 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
696
CY2023 us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
1450000
CY2022 us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
2888787
CY2021 us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
0
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
7338
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-848
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-25983
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-254109
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-969374
CY2023 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-6726
CY2022 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-37853
CY2021 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
43750
CY2023 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-262192
CY2022 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
149178
CY2021 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
113014
CY2023 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-1417
CY2022 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
1511
CY2021 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
0
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-91348
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-495668
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
74120
CY2023 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
163500
CY2022 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
36553
CY2021 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
-78932
CY2023 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
347567
CY2022 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
349436
CY2021 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
0
CY2023 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
99649
CY2022 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
304576
CY2021 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-123052
CY2023 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
992277
CY2022 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
126228
CY2021 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
12025
CY2023 tirx Increase Decrease In Operating Lease Liabilities Related Party
IncreaseDecreaseInOperatingLeaseLiabilitiesRelatedParty
0
CY2022 tirx Increase Decrease In Operating Lease Liabilities Related Party
IncreaseDecreaseInOperatingLeaseLiabilitiesRelatedParty
0
CY2021 tirx Increase Decrease In Operating Lease Liabilities Related Party
IncreaseDecreaseInOperatingLeaseLiabilitiesRelatedParty
-29355
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-80316
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-189012
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-194341
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
994304
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-198760
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1363938
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2346
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3411
CY2023 tirx Payments To Notes Receivable
PaymentsToNotesReceivable
7800000
CY2022 tirx Payments To Notes Receivable
PaymentsToNotesReceivable
0
CY2021 tirx Payments To Notes Receivable
PaymentsToNotesReceivable
7500000
CY2023 us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
7500000
CY2022 us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
0
CY2021 us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
0
CY2023 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
27779231
CY2022 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
29011783
CY2021 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0
CY2023 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
27086514
CY2022 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
116663
CY2021 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
0
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-992717
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-28897466
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7503411
CY2023 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
75581
CY2023 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
75581
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
9535
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
225171
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1893932
CY2023 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
9818
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
225171
CY2021 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
2272145
CY2023 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
12300000
CY2023 us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
0
CY2022 us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
0
CY2021 us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
1489388
CY2023 tirx Proceedsfromissuancejune2021initialpublicoffering
Proceedsfromissuancejune2021initialpublicoffering
0
CY2022 tirx Proceedsfromissuancejune2021initialpublicoffering
Proceedsfromissuancejune2021initialpublicoffering
0
CY2021 tirx Proceedsfromissuancejune2021initialpublicoffering
Proceedsfromissuancejune2021initialpublicoffering
24562500
CY2023 tirx Paymentsforrepurchaseofjune2021initialpublicoffering
Paymentsforrepurchaseofjune2021initialpublicoffering
0
CY2022 tirx Paymentsforrepurchaseofjune2021initialpublicoffering
Paymentsforrepurchaseofjune2021initialpublicoffering
0
CY2021 tirx Paymentsforrepurchaseofjune2021initialpublicoffering
Paymentsforrepurchaseofjune2021initialpublicoffering
2352418
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-283
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
32642481
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-1471
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-1052173
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
145014
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-167
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-30148399
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
23920146
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
695242
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30843641
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6923495
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
695075
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
695242
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30843641
CY2023 us-gaap Interest Paid Net
InterestPaidNet
0
CY2022 us-gaap Interest Paid Net
InterestPaidNet
22
CY2021 us-gaap Interest Paid Net
InterestPaidNet
725
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
807
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2251
CY2023 tirx Non Cash Investing And Financing Activities On Reissuance Of Treasury Stock
NonCashInvestingAndFinancingActivitiesOnReissuanceOfTreasuryStock
25000
CY2022 tirx Non Cash Investing And Financing Activities On Reissuance Of Treasury Stock
NonCashInvestingAndFinancingActivitiesOnReissuanceOfTreasuryStock
0
CY2021 tirx Non Cash Investing And Financing Activities On Reissuance Of Treasury Stock
NonCashInvestingAndFinancingActivitiesOnReissuanceOfTreasuryStock
0
CY2023 tirx Payments Made By Related Parties On Company S Behalf
PaymentsMadeByRelatedPartiesOnCompanySBehalf
1068700
CY2022 tirx Payments Made By Related Parties On Company S Behalf
PaymentsMadeByRelatedPartiesOnCompanySBehalf
0
CY2021 tirx Payments Made By Related Parties On Company S Behalf
PaymentsMadeByRelatedPartiesOnCompanySBehalf
119886
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2508
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30024372
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6137689
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
692734
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
819269
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
785806
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
695242
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30843641
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6923495
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2383
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2508
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30024372
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
692692
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
692734
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
819269
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
695075
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
695242
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30843641
CY2019Q2 tirx Number Of Majority Shareholders
NumberOfMajorityShareholders
2
CY2019Q2 tirx Controlled Entities Incorporated Percent
ControlledEntitiesIncorporatedPercent
1
CY2023 tirx Share Disposal And Exclusive Option To Purchase Agreement Term
ShareDisposalAndExclusiveOptionToPurchaseAgreementTerm
P20Y
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Changes in these estimates and assumptions may have a material impact on the consolidated financial statements and accompanying notes. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Significant estimates during the years ended October 31, 2023, 2022 and 2021 include the assumptions used in assessing impairment of long-term assets, the valuation of deferred tax assets and associated valuation allowances, the determination of the fair value of the warrants, and the valuation of stock-based compensation.</p>
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
26797081
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
26179662
CY2023Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
2383
CY2023 tirx Concentration Risk Percentage
ConcentrationRiskPercentage
1.000
CY2022Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
2508
CY2022 tirx Concentration Risk Percentage
ConcentrationRiskPercentage
1.000
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 7pt 0pt;">Concentration of Credit Risk and Uncertainties</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 7pt 0pt;">The ramifications of the outbreak of the novel strain of COVID-19, reported to have started in December 2019 and spread globally, are filled with uncertainty and changing quickly. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 7pt 0pt;">The Company is operating in a rapidly changing environment so the extent to which COVID-19 impacts its business, operations and financial results from this point forward will depend on numerous evolving factors that the Company cannot accurately predict. Those factors include the following: the duration and scope of the pandemic; governmental, business and individuals’ actions that have been and continue to be taken in response to the pandemic.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 7pt 0pt;">A portion of the Company’s cash is maintained with state-owned banks within the PRC. Balances at state-owned banks within the PRC are covered by insurance up to RMB 500,000 (approximately $68,000) per bank. Any balance over RMB 500,000 per bank in PRC will not be covered. At October 31, 2023, cash balances held in the PRC were RMB 5,085,934 (approximately $695,000), of which, RMB 4,561,614 (approximately $623,000) was not covered by such limited insurance. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant risks on its cash in bank accounts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 7pt 0pt;">Currently, the Company’s operations are carried out in China. Accordingly, the Company’s business, financial condition and results of operations may be influenced by the political, economic and legal environment in China, and by the general state of China’s economy. The Company’s operations in China are subject to specific considerations and significant risks not typically associated with companies in North America. The Company’s results may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion and remittance abroad, and rates and methods of taxation, among other things.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 7pt 0pt;">Financial instruments which potentially subject the Company to concentrations of credit risk consist principally of trade accounts receivable. A portion of the Company’s sales are credit sales to customers whose ability to pay are dependent upon the prevailing industry economics; however, concentration of credit risk with respect to trade accounts receivable is limited due to short-term payment terms. The Company also performs ongoing credit evaluations of its customers to help further reduce credit risk.</p>
CY2023 us-gaap General Insurance Expense
GeneralInsuranceExpense
500000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
26797081
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
26179662
CY2023 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
692733
CY2022 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
282968
CY2021 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
0
CY2023 tirx Allowance For Cancellation
AllowanceForCancellation
0
CY2022 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
123646
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
0
CY2023 tirx Value Added Tax Rate
ValueAddedTaxRate
0.06
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1244247
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1351909
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2790617
CY2023 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
45244
CY2022 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
146431
CY2021 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
166242
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2438248
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1764909
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2517497
CY2023 us-gaap Advertising Expense
AdvertisingExpense
979694
CY2022 us-gaap Advertising Expense
AdvertisingExpense
837807
CY2021 us-gaap Advertising Expense
AdvertisingExpense
2466239
CY2022 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2023 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2023Q4 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
7.3171
CY2022Q4 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
7.3029
CY2023 tirx Average Foreign Currency Exchange Rate Translation
AverageForeignCurrencyExchangeRateTranslation
7.0584
CY2022 tirx Average Foreign Currency Exchange Rate Translation
AverageForeignCurrencyExchangeRateTranslation
6.6166
CY2021 tirx Average Foreign Currency Exchange Rate Translation
AverageForeignCurrencyExchangeRateTranslation
6.4831
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
141800
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
141800
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
141800
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023 us-gaap Fiscal Period
FiscalPeriod
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 7pt 0pt;">Fiscal Year End</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 7pt 0pt;">The Company has adopted a fiscal year end of October 31st.</p>
CY2022Q4 tirx Prepaid Professional Fees
PrepaidProfessionalFees
108345
CY2023Q4 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
38641
CY2022Q4 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
33553
CY2023Q4 us-gaap Deposit Assets
DepositAssets
17716
CY2022Q4 us-gaap Deposit Assets
DepositAssets
24251
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
16546
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
12137
CY2023Q4 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
34605
CY2022Q4 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
10749
CY2023Q4 us-gaap Other Assets
OtherAssets
107508
CY2022Q4 us-gaap Other Assets
OtherAssets
189035
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
107508
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
168957
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
20078
CY2023Q4 us-gaap Other Assets
OtherAssets
107508
CY2022Q4 us-gaap Other Assets
OtherAssets
189035
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
51022
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
53846
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
44742
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
45158
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6280
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8688
CY2023 us-gaap Depreciation
Depreciation
1631
CY2022 us-gaap Depreciation
Depreciation
3663
CY2021 us-gaap Depreciation
Depreciation
7862
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
623812
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
465291
CY2023Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
0
CY2022Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
458
CY2023Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
13
CY2022Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1129
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
623825
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
466878
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
364840
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
310476
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
116961
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
74417
CY2023Q4 tirx Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
481801
CY2022Q4 tirx Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
384893
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1173510
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
126530
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2292643
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
4660550
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1920048
CY2023 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0
CY2023 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
161339
CY2022 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
23639
CY2021 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
24529
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
161339
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23639
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24529
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
84474
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
107858
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
16546
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
12137
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
84474
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
107858
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
16546
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
12137
CY2023 tirx Limitation Of Statute Extended Period
LimitationOfStatuteExtendedPeriod
P3Y
CY2023Q4 tirx Limitation Of Extended Income Tax Liability
LimitationOfExtendedIncomeTaxLiability
100000
CY2023Q4 tirx Limitation Of Extended Income Tax Liability
LimitationOfExtendedIncomeTaxLiability
14000
CY2022Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
0
CY2023Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
0
CY2023 us-gaap Common Stock Voting Rights
CommonStockVotingRights
eighteen
CY2021Q2 tirx Agent Fees And Other Offering Expenses
AgentFeesAndOtherOfferingExpenses
2362156
CY2021Q2 tirx Adjustments To Additional Paid In Capital Direct Cost
AdjustmentsToAdditionalPaidInCapitalDirectCost
911647
CY2021Q2 tirx Stock Issued During Period Value As Offset To Direct Costs
StockIssuedDuringPeriodValueAsOffsetToDirectCosts
1450509
CY2022 tirx Cash Or Other Assets Transferred
CashOrOtherAssetsTransferred
0
CY2020Q4 us-gaap Minority Interest
MinorityInterest
495
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-28
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest
22
CY2021Q4 us-gaap Minority Interest
MinorityInterest
489
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-32
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest
-57
CY2022Q4 us-gaap Minority Interest
MinorityInterest
400
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-5
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest
-1
CY2023Q4 us-gaap Minority Interest
MinorityInterest
394
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
75000
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
316000
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
242000
CY2023 tirx Schedule Of Supplemental Cash Flow Information Related To Leases
ScheduleOfSupplementalCashFlowInformationRelatedToLeases
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:62.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:35.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">Years Ended October 31,</p></td></tr><tr><td style="vertical-align:bottom;width:62.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">2021</p></td></tr><tr><td style="vertical-align:bottom;width:62.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cash paid for amounts included in the measurement of lease liabilities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:62.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Operating cash flows paid for operating lease</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 85,372</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 231,421</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 293,078</p></td></tr><tr><td style="vertical-align:bottom;width:62.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Right-of-use assets obtained in exchange for lease obligation:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Operating lease</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 35,666</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 174,824</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 544,515</p></td></tr></table>
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
85372
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
231421
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
293078
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
35666
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
174824
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
544515
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y11M8D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0475
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
58341
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
58341
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
939
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
57402
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
57402
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
57402

Files In Submission

Name View Source Status
0001410578-24-001091-index-headers.html Edgar Link pending
0001410578-24-001091-index.html Edgar Link pending
0001410578-24-001091.txt Edgar Link pending
0001410578-24-001091-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tirx-20231031.xsd Edgar Link pending
tirx-20231031x20f.htm Edgar Link pending
tirx-20231031x20f001.jpg Edgar Link pending
tirx-20231031x20f002.jpg Edgar Link pending
tirx-20231031xex12d1.htm Edgar Link pending
tirx-20231031xex12d2.htm Edgar Link pending
tirx-20231031xex13d1.htm Edgar Link pending
tirx-20231031xex13d2.htm Edgar Link pending
tirx-20231031xex15d1.htm Edgar Link pending
tirx-20231031xex15d1001.jpg Edgar Link pending
tirx-20231031xex15d1002.jpg Edgar Link pending
tirx-20231031xex15d2.htm Edgar Link pending
tirx-20231031xex1d1.htm Edgar Link pending
tirx-20231031xex2d4.htm Edgar Link pending
tirx-20231031xex4d15.htm Edgar Link pending
tirx-20231031xex8d1.htm Edgar Link pending
tirx-20231031xex97d1.htm Edgar Link pending
tirx-20231031xex97d2.htm Edgar Link pending
tirx-20231031_lab.xml Edgar Link unprocessable
tirx-20231031_pre.xml Edgar Link unprocessable
tirx-20231031_cal.xml Edgar Link unprocessable
tirx-20231031_def.xml Edgar Link unprocessable
tirx-20231031x20f_htm.xml Edgar Link completed